newsfilter
← Latest News
Business Wire·

Tivic Expands Intellectual Property Portfolio

New Biologics Patent Application Covers Potential Applicability of TLR5 Agonists to Improve Outcomes for Late-stage Cancer Therapies; Bioelectronic Patent Covers Optimized ncVNS Device Specifications Tivic